Wales and NI follow England in backing Vertex CF therapies
Three of the four UK nations have agreed a long-term deal with Vertex Pharma for reimbursement of its cystic fibrosis therapies, ensuring permanent access to the drugs for eligible patients
EvolutionaryScale emerges with $142m for AI drug discovery
Former Meta researchers working on artificial intelligence (AI) and large language models (LLMs) to find protein drugs have banded together to form a start-up called EvolutionaryScale.
Akili lifted by FDA nod for adult ADHD digital therapeutic
Akili’s new era as a subsidiary of Virtual Therapeutics will start with FDA approval of its digital therapeutic for attention-deficit hyperactivity disorder (ADHD) in adults, a key part of
Mistrust in healthcare is hitting clinical trial enrolment
A survey of pharma industry executives has found that a third of them believe mistrust in the healthcare system has become a significant barrier to getting a diverse range of people to sign
Imfinzi fails lung cancer trial, but scores in bladder cance...
AstraZeneca’s hopes of positioning its PD-L1 inhibitor Imfinzi as a post-surgery therapy for people with earlier-stage lung cancer have taken a knock, although it performed well in a bladde
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
5th Gene Therapy for Ophthalmic Disorders Summit
Ophthalmic drug developers are unlocking the full potential of gene therapy.
4th Inner Ear Disorders Therapeutics Summit
2024 has started off with a bang with recent back-to-back positive results for gene therapy for rare genetic hearing disorders and major headways in otoprotective, restorative and regenerative smal
Executive Education: Pharmaceuticals and the Law
A new executive education programme from The British Institute of International and Comparative Law (BIICL) and the Centre for Commercial law Studies
6th RAS-Targeted Drug Development Summit
Overcome Diverse Clinical Resistance Mechanisms with Emerging First- & Best-In-Class Combination & Monotherapies to Effectively Treat Patients with RA
12th IMPACCT Real World Evidence Summit
The 12th IMPACCT Real World Evidence Summit is the only industry meeting dedicated to uniting experts in RWE and Evidence Generation to consolidate, innovate and apply RWE across the drug developme